Gastrointestinal drugs

Merlob, Paul; Weber-Schöndorfer, Corinna

doi:10.1016/b978-0-12-408078-2.00028-7

Cited by 1 publication

(6 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Domperidone within the labeled dosing regimen and duration is generally considered safe to use during breastfeeding 35 . It is present only in minimal concentrations in breastmilk.…”

Section: Drug Safetymentioning

confidence: 99%

“…The relative infant dose is 0.4%, indicating the weight-adjusted intake of the breastfed child as compared to the nursing mother's weight-adjusted intake. No reports of adverse reactions in breastfed infants have been reported 35 . There is only very limited experience with the safety during breastfeeding in higher dosing regimens and longer treatment periods 36…”

Section: Drug Safetymentioning

confidence: 99%

“…Metoclopramide within the labeled dosing regimen and duration is generally considered safe to use during breastfeeding 35 . There have been few reports of adverse reactions, such as increased gas formation and gastrointestinal discomfort, in breastfed infants 41 .…”

Section: Drug Safetymentioning

confidence: 99%

“…34 Domperidone within the labeled dosing regimen and duration is generally considered safe to use during breastfeeding. 35 It is present only in minimal concentrations in breastmilk. The relative infant dose is 0.4%, indicating the weightadjusted intake of the breastfed child as compared to the nursing mother's weight-adjusted intake.…”

Section: Domperidonementioning

confidence: 99%

“…No reports of adverse reactions in breastfed infants have been reported. 35 There is only very limited experience with the safety during breastfeeding in higher dosing regimens and longer treatment periods. 36…”

Section: Domperidonementioning

confidence: 99%

See 4 more Smart Citations

Safety of pharmacologically induced lactation

Thøgersen,

Gotfredsen,

Gade

et al. 2023

Adverse Drug Reaction Bulletin

View full text Add to dashboard Cite

Summary Pharmacologically induced lactation has the potential to help parents of all sexes who wish to breastfeed their children without a preceding pregnancy, and the interest in this possibility is increasing. A combination of hormones, physical stimulation and domperidone to mimic the hormonal changes of pregnancy and birth can be used to induce lactation. However, off-label uses of estrogen, progestin and domperidone or metoclopramide in high doses and for a long period of time have been associated with adverse drug reactions. Before prescribing drugs for induced lactation, it is important to discuss and help manage the parent's expectations regarding the outcome and, in detail, discuss the potential risks.

show abstract

“…Domperidone within the labeled dosing regimen and duration is generally considered safe to use during breastfeeding 35 . It is present only in minimal concentrations in breastmilk.…”

Section: Drug Safetymentioning

confidence: 99%

Section: Drug Safetymentioning

confidence: 99%

Section: Drug Safetymentioning

confidence: 99%

Section: Domperidonementioning

confidence: 99%

Section: Domperidonementioning

confidence: 99%

See 3 more Smart Citations

Safety of pharmacologically induced lactation

Thøgersen,

Gotfredsen,

Gade

et al. 2023

Adverse Drug Reaction Bulletin

View full text Add to dashboard Cite

show abstract

Gastrointestinal drugs

Cited by 1 publication

References 27 publications

Safety of pharmacologically induced lactation

Safety of pharmacologically induced lactation

Contact Info

Product

Resources

About